Table 2.
PD-L1 | All Cases | Pleural Effusions | Bronchial Brushes | Bronchoalveolar Lavages | |
---|---|---|---|---|---|
Cutoff ≥1% positive cells (95% CI) |
Kappa (κ) | 0.70 (0.56–0.83) | 0.48 (0.08–0.87) | 0.55 (0.21–0.90) | 0.81 (0.66–0.95) |
OPA | 85 (77–91) | 74 (51–89) | 76 (52–91) | 91 (81–96) | |
PPA | 89 (77–95) | 70 (39–90) | 100 (56–100) | 92 (78–98) | |
NPA | 81 (67–90) | 78 (44–95) | 64 (35–85) | 89 (71–97) | |
McNemar | 0.61 | 1.00 | 0.134 | 0.683 | |
Cutoff ≥5% positive cells (95% CI) |
Kappa (κ) | 0.53 (0.37–0.70) | 0.42 (−0.01–0.84) | 0.65 (0.32–0.99) | 0.53 (0.33–0.74) |
OPA | 77 (68–84) | 74 (51–89) | 82 (58–95) | 77 (65–85) | |
PPA | 73 (59–84) | 57 (25–84) | 100 (56–100) | 72 (54–85) | |
NPA | 80 (67–89) | 83 (54–97) | 73 (43–91) | 81 (64–91) | |
McNemar | 1.00 | 1.00 | 0.248 | 0.606 | |
Cutoff ≥10% positive cells (95% CI) |
Kappa (κ) | 0.51 (0.34–0.69) | 0.07 (−0.39–0.52) | 0.64 (0.29–0.99) | 0.56 (0.35–0.76) |
OPA | 77 (68–84) | 68 (46–85) | 82 (58–95) | 78 (66–87) | |
PPA | 71 (55–83) | 20 (2–64) | 100 (51–100) | 75 (56–88) | |
NPA | 81 (69–89) | 86 (59–97) | 75 (46–92) | 81 (65–91) | |
McNemar | 1.00 | 0.683 | 0.248 | 0.789 | |
Cutoff ≥50% positive cells (95% CI) |
Kappa (κ) | 0.53 (0.34–0.72) | −0.16 (−0.33–0.00) | 0.85 (0.57–1.00) | 0.58 (0.36–0.80) |
OPA | 82 (73–89) | 68 (46–85) | 94 (71–100) | 83 (72–90) | |
PPA | 63 (44–79) | 00 (00–55) | 100 (45–100) | 68 (46–85) | |
NPA | 89 (80–95) | 87 (61–98) | 92 (65–100) | 89 (76–96) | |
McNemar | 0.81 | 0.683 | 1.00 | 1.00 |
Kappa (κ) is presented as range −1–1. OPA, PPA, and NPA are presented as percent with histology as the non-reference standard. McNemar analyses are presented as p-values; CI: confidence interval; Kappa (κ): Cohen’s kappa coefficient; NPA: Negative Percentage Agreement; OPA: Overall Percentage Agreement; PPA: Positive Percentage Agreement.